secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuo Therapeutics, Inc. (AURX)
CIK:        0001091596
Form:       8-K
Filed at:   2022-12-05T23:59:59+00:00
Accession:  0001437749-22-028414
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Nuo Therapeutics shareholders approve all proposals at 2022 annual meeting
--------------------------------------------------------------------------

- Re-elected David E. Jorden, C. Eric Winzer, Scott M. Pittman, and Paul D. Mintz as directors.
- Ratified Marcum LLP as independent auditor for FY2022 with 27,697,944 votes for, 1,074 against.
- Advisory vote on executive compensation approved with 26,692,397 for, 5,370 against, 5,000 abstain.
- Advisory vote on frequency set to every three years based on 23,767,794 votes for three years.
- Approved amendment to 2016 Omnibus Incentive Compensation Plan with 26,188,825 for, 7,988 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1091596/000143774922028414/0001437749-22-028414-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1091596/000143774922028414/aurx20221202b_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-028414

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer